Vascular endothelial growth factor confers a growth advantage in vitro and in vivo to stromal cells cultured from neonatal hemangiomas.
M. Bérard(Centre National de la Recherche Scientifique), Jean Plouët, Nathalie Ortéga, Nicolas Bertrand(Institut Arnault Tzanck), Sylvie Sordello, N Peyri, L. Drouet, O Enjolras(Hôpital Armand-Trousseau), J L Carrier, Michel Wassef(Université Paris Cité)
PubMed
April 1, 1997
Cited by 59
Related Papers
Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies
|PEDIATRICS|2015|1.4k
Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics
|Nature Communications|2017|679
Infants with Kasabach-Merritt syndrome do not have “true” hemangiomas
|The Journal of Pediatrics|1997|499
Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused byRASA1 mutations
|Human Mutation|2008|429
Rapidly Involuting Congenital Hemangioma: Clinical and Histopathologic Features
|Pediatric and Developmental Pathology|2003|360